Bone involvement is a common, painful, and debilitating aspect of systemic masocytosis. It is not clear why systemic mastocytosis causes bone pain in the absence of fractures; however, long delays in making the diagnosis of systemic mastocytosis are not unusual and may allow progression of bone disease. Histopathologic patterns of bone marrow mast cell involvement have been identified as 1) focal mast cell aggregates in peritrabecular and perivascular areas often with increased numbers of eosinophils, and a dense network of reticulin fibers; 2) peritrabecular and perivascular sheets of mast cells accompanied by fibrosis and osteosclerosis; or 3) diffuse infiltration by atypical mast cells with marked hypoplasia of fat cells and blood precursors. This is a Phase I study to examine the effectiveness of low-dose mithramycin to relieve bone pain in patients with systemic mastocytosis. The clinical response to mithromycin will be evaluated by assessment of pain status and pain medication use prior to and following treatment. Functional status will be monitored with the Health Status Questionnaire (HSQ). Patient recruitment has been frustrating. The reason is not entirely clear, but I believe it is due to several factors: 1) patient resistance to pay expenses for travel to Rochester and preliminary costs for diagnosis of systemic mastocytosis; and 2) the normal ebb and flow of patients with rare disease who are seen at one institution. I have announced this protocol in the Mastocytosis Society Newsletter and have made announcements on the Mastocytosis Society's web page. I have been in touch with numerous physicians who refer patients with mastocytosis and have informed them of the study. I have also called patients directly to discuss the protocol.. I believe we will get the patient enrollment, but the time course of this enrollment is not clear.

Project Start
1998-12-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
28
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Kamimura, Daisuke; Suzuki, Takeki; Wang, Wanmei et al. (2018) Higher plasma leptin levels are associated with reduced left ventricular mass and left ventricular diastolic stiffness in black women: insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Hypertens Res 41:629-638
Nowak, Kristen L; You, Zhiying; Gitomer, Berenice et al. (2018) Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol 29:571-578
Tirumanisetty, P; Prichard, D; Fletcher, J G et al. (2018) Normal values for assessment of anal sphincter morphology, anorectal motion, and pelvic organ prolapse with MRI in healthy women. Neurogastroenterol Motil 30:e13314
McKenzie, Katelyn A; El Ters, Mirelle; Torres, Vicente E et al. (2018) Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort. BMC Nephrol 19:378
Dad, Taimur; Abebe, Kaleab Z; Bae, K Ty et al. (2018) Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep 3:619-624
Yu, Alan S L; Shen, Chengli; Landsittel, Douglas P et al. (2018) Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease. Kidney Int 93:691-699
Brosnahan, Godela M; Abebe, Kaleab Z; Rahbari-Oskoui, Frederic F et al. (2017) Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials. Curr Hypertens Rev 13:109-120
Kamimura, Daisuke; Suzuki, Takeki; Furniss, Anna L et al. (2017) Elevated serum osteoprotegerin is associated with increased left ventricular mass index and myocardial stiffness. J Cardiovasc Med (Hagerstown) 18:954-961
Chung, Jin Ook; Koutsari, Christina; Blachnio-Zabielska, Agnieszka U et al. (2017) Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans. Diabetes 66:2082-2091
West, Nancy A; Lirette, Seth T; Cannon, Victoria A et al. (2017) Adiposity, Change in Adiposity, and Cognitive Decline in Mid- and Late Life. J Am Geriatr Soc 65:1282-1288

Showing the most recent 10 out of 1267 publications